April 17th 2025
How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.
April 15th 2025
Why a fundamental rethinking of how manufacturers engage with healthcare providers, payers, and patients is necessary in today's pharma landscape.
April 14th 2025
The Verseon CEO discusses how this advanced technology is helping to discover new drug candidates.
April 10th 2025
As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
April 9th 2025
Hyfe’s CEO discusses the importance of DTx and how it can change the way certain conditions are treated.
Global Dermatology Market Set to Reach $33.7 Billion by 2022 Despite Patent Expiries
May 04, 2016.
Valeant Board Shake-Up
May 03, 2016.
Clinical Trials Awareness Week Begins
EMD Serono Expansion to Create 150 New Jobs in Massachusetts
IMS and Quintiles Announce Merger
Combined company will have market value of around $18 billion, reports Reuters.
GSK Gel Endorsed by EMA to Prevent Umbilical Cord Infections Outside EU
April 29, 2016.
Pharma Failing to Improve Gender Diversity in Workforce
Hematological Cancers Market Expected to "More Than Double" by 2022
April 28, 2016.
AbbVie to Acquire Stemcentrx
Data Unleashed: Cooperation Among Competitors
Charting two years of collaborative progress in clinical trial data sharing.
Italy's Industry Value to Drop to $18.6 Billion by 2020
April 27, 2016.
WHO Releases Report on Eliminating Malaria
April 26, 2016.
Disease Interception and the US National Cancer Moonshot
World Excipients Market to Reach $6.4 Billion by 2020, Says Report
Pharm Exec's Emerging Pharma Leaders 2016 — Last Chance to Nominate
March 23, 2016.
Perrigo Confirms Papa Exit
April 25, 2016.
AZ Forms News Collaboration with "Genomics Community"
Europe: Orphans Under Attack Again
April, 21, 2016.
FDA's Breakthrough Designation is Working, Says Report
April 21, 2016.
European Physicians Want More Detail on Biosimilar Labels
April 19, 2016.
Shire Announces $400 Million Ireland Investment
April 18, 2016.
Global Viral Infections Market to Reach $117.6 Billion by 2021
April 14, 2016.
Schizophrenia Treatment Pipeline "Weak" But Has Potential
April 13, 2016.
Pressure Builds to Revamp Off-Label Marketing Rules
April 12, 2016.
FDA Approves Remicade Biosimilar
More than a year after approving its first biosimilar, FDA has authorized a second therapy in this category.
FDA Releases Draft Guidance on Labeling of Biosimilars
April 04, 2016.
Anti-Vaccine Movement Rears Its Ugly Head Again
SXSW 2016 & The New Alchemy of Hope
In many life situations, it’s difficult to be hopeful. But at SxSW Interactive last week, it was difficult to be pessimistic, writes Bill Drummy.
EMA Publishes Parallel Scientific Advice Report
March 31, 2016.
US Opioid Market to Reach $17.7 Billion by 2021, Says Report